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Lay Summary 
 
The study analyzed the consistency of patterns of brain waves and rhythms in those affected 
with a loss or gain of DNA material in the 16p11.2 region. Compared with typical 
individuals, 16p11.2 deletion carriers showed greater inconsistency in the way the brain 
responds to the same visual event. This high inconsistency in brain activity may play a role in 
some core symptoms in 16p11.2 copy number variation carriers.  
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Abstract 
 
Copy number variations (CNVs) at the 16p11.2 chromosomal region are associated with 
myriad clinical features including intellectual disability and autism spectrum disorder. The 
aim of this study is to determine whether 16p11.2 deletion (DEL) and duplication (DUP) 
carriers demonstrate a distinct and reciprocal pattern of electroencephalography (EEG) 
activity as represented by neural variability measures. EEG data were previously collected as 
part of the Simons Variation in Individuals Project. Variability measures, as estimated by 
VLQJOHဨWULDO(53DQGspectral power analyses in the alpha and beta frequency bands, in 
DGGLWLRQWRVLJQDOဨWRဨQRLVHUDWLRV615VZHUHDQDO\]HGLQ'(/n = 20), DUP (n = 8), and 
typical (n = 11) groups. We also analyzed mean visual evoked potentials and spectral power 
(alpha and beta power) to facilitate comparisons with other studies of associated disorders 
DQG&19V)URPPHDVXUHVRIVLQJOHဨWULDOYDULDELOLW\ZHIRXQGKLJKHULQWUDSDUWLFLSDQW
variability in P1 amplitude and timecourse amplitude in DEL compared to controls. 
Compared to DUP, DEL showed higher variability in absolute alpha and absolute beta power 
but lower variability in P1 latency. SNRs did not differ between the groups. From measures 
of amplitude, latency, and spectral power, DUP showed lower relative alpha power compared 
to controls. Although it is yet unclear whether 16p11.2 CNV dosage impacts neural activity 
in an opposing manner, findings suggest that 16p11.2 DEL impacts the level of variability of 
neural responses. Higher neural variability may play a role in a range of cognitive processes 
in 16p11.2 CNV carriers.  
 
Keywords: Alpha Rhythm, Genetic/Genomic Syndromes, Electroencephalography (EEG), 
Copy Number Variation/ Copy Number Variants (CNV), Cognitive Neuroscience, Event-
Related Potentials (ERP), Gene-Dosage Effect.  
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Introduction 
 
&RS\QXPEHUYDULDWLRQV&19VDWWKHSFKURPRVRPDOUHJLRQa(?NEEUHDNSRLQWV±
5 [BP4±BP5]) are associated with myriad clinical features including intellectual disability, 
autism spectrum disorder (ASD), epilepsy, and language and motor delays [Weiss et 
al., 2008; McCarthy et al., 2009; Hanson et al., 2015; D'angelo et al., 2016; Snyder et 
al., 2016; Steinman et al., 2016]. This CNV is associated with a variable phenotype, in terms 
of the clinical profile and degree of symptom severity [Golzio & Katsanis, 2013; D'angelo et 
al., 2016; Snyder et al., 2016; Steinman et al., 2016]. The 16p11.2 chromosomal region spans 
approximately 29 genes, including MAPK3 and MVP²both potentially influencing synaptic 
function and cortical plasticity [Park, Park, & Lee, 2017]. The loss (DEL) or gain (DUP) of 
these ~29 genes in the 16p11.2 has a population prevalence of ~0.05% for DEL and ~0.04% 
for DUP [Kirov et al., 2014]. Although rare, 16p11.2 CNVs are one of the most common risk 
factors for ASD (contributing up to ~1% of ASD cases) [Weiss et al., 2008; Sanders et 
al., 2011] and other disorders [e.g. Marshall et al., 2017]. When inherited the pattern of 
inheritance is autosomal dominant, however, de novo 16p11.2 DEL and DUP cases are also 
frequently reported [Sanders et al., 2011; Steinman et al., 2016]. 
Regardless of inheritance status, many studies have consistently drawn the conclusion that 
the number of 16p11.2 copies may lead to observed opposing effects in certain phenotypes on 
GHOHWLRQVYHUVXVGXSOLFDWLRQVZKLFKLVLQGLFDWLYHRIDJHQHဨGRVDJHHIIHFW>6KLQDZLHW
al., 2010; Jacquemont et al., 2011; Owen, 2014; Qureshi et al., 2014; Maillard et al., 2015; 
Arbogast et al., 2016; Chang et al., 2016; Hippolyte et al., 2016; Jenkins et al., 2016; LeBlanc 
& Nelson, 2016; Steinman et al., 2016]. For example, 16p11.2 DEL is associated with 
atypically large brain volume, whereas DUP is associated with atypically small brain volume 
[Qureshi et al., 2014]. Investigating wKHWKHUSDUWLFXODUS&19SKHQRW\SHVDUHJHQHဨ
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dosage dependent or independent is important because it connects genotype to phenotype, 
enabling a deeper understanding of the pathological effects of 16p11.2 CNVs. 
Further evidence to indications of 16p11.&19JHQHဨGRVDJHHIIHFWVKDYHEHHQIRXQGLQWKH
form of M/EEG signals (or neurophysiological EEG and MEG activity) [Jenkins et al., 2016; 
LeBlanc & Nelson, 2016]. Specifically, Jenkins et al. [2016] found a significant delay in the 
0UHVSRQVHLHDW\SLFDOZDYHIRUPHOLFLWHGDWa(?PVSRVWVWLPXOXVRQVHWLQUHVSRQVHWR
auditory events) in DEL compared to controls, whereas DUP showed an earlier 
(nonsignificant) M100 response compared to controls. Examining the amplitude of the P1 
component (i.e., the equivalent of the M100 response, but to visual events), LeBlanc and 
Nelson [2016] similarly found opposing neural activity in DEL and DUP. In this case, a trend 
(albeit nonsignificant) of higher P1 amplitude in DEL compared to controls and lower P1 
amplitude in DUP compared to controls. Notably, when DEL and DUP were compared to 
each other directly, a significant difference in P1 amplitude was found: DEL showed higher 
P1 amplitude than DUP. Certainly, as captured by M/EEG, these studies showed that 16p11.2 
&19FDUULHUVKDYHDW\SLFDOQHXUDODFWLYLW\ZKLFKVHHPVWREHLQIOXHQFHGE\JHQHဨGRVDJH
Hudac et al. [2015] also contributed toward phenotyping the EEG behavior of 16p11.2 
carriers. The authors studied power changes in the mu frequency band (8±(?+]WRVRFLDO
and nonsocial motion. Typically, a greater attenuation in the mu band is expected in response 
to social stimuli, however, the CNV groups showed greater mu attenuation to nonsocial than 
VRFLDOVWLPXOL&UXFLDOO\WKLVVWXG\DOVRFRQGXFWHGWULDOဨWRဨWULDODQDO\VLVWRH[DPLQHZKHWKer 
the level of mu attenuation was altered differently over time between groups. They found that 
unique to DUP, an initial typical mu response was exhibited, which then decreased over time 
more rapidly compared to controls. Overall, even though no opposing EEG activity was 
found in 16p11.2 CNV group by Hudac et al. [2015@WULDOဨWRဨWULDODQDO\VLVUHYHDOHGWKDW
DUP's initial typical response distinguished it from DEL. Indeed, further research using other 
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PHDVXUHVRIQHXUDODFWLYLW\HVSHFLDOO\WULDOဨWRဨWULDOYDULDELOLW\PHDVXUHVLVZDUUDQWHGWR
verify distinct and potentially reciprocal EEG responses in 16p11.2 CNV carriers. 
In the ASD literature [Haigh, Heeger, Dinstein, Minshew, & Behrmann, 2015; Dinstein et 
al., 2012; Milne, 2011], variability measures for both M/EEG and functional magnetic 
UHVRQDQFHLPDJLQJI05,UHVSRQVHVKDYHEHHQFRPSXWHGWRVWXG\LQWUDSDUWLFLSDQWWULDOဨWRဨ
trial neural variability via visual, somatosensory, and auditory paradigms. Despite finding no 
differences in the mean measures of stimulus±response amplitude, these studies identified 
neural responses that were variable across single trials in the ASD group relative to the 
W\SLFDOJURXS&RQGXFWLQJWULDOဨWRဨWULDOYDULDELOLW\DQDO\VHVWKHUHIRUHLVXVHIXOLQLGHQWLI\LQJ
these subtle yet significant differences in neural responses between clinical and typical 
populations, which would have been unnoticed in meDVXUHVRIDYHUDJHGဨWULDOUHVSRQVHV
Neural variability in clinical populations has been increasingly studied and recognized as a 
useful sign of a typical brain function and development [Pernet, Sajda, & Rousselet, 2011; 
Garrett et al., 2013; Dinstein et al., 2015; David et al., 2016]. Overall, intraindividual 
variability measures and analyses (e.g., multiple M/EEG and fMRI variability metrics) could 
present a possibly unifying multimodal approach to studying 16p11.2 CNV and, more 
generally, subtle differences in heterogeneous disorders that vary in their symptomology and 
severity from one person to another. 
The purpose of the current study is to further determine the nature of the putative atypical and 
reciprocal EEG activity in 16p11.2 DEL and DUP carriers. To our knowledge, no existing 
study has investigated neural variability in this population. As such the current study 
conducts novel analyses of the dataset previously published by LeBlanc and Nelson [2016]. 
Neural variability was measured via the following metrics: intraparticipant response 
YDULDELOLW\RIYLVXDOHYRNHGFRPSRQHQWVLHDFURVVဨWULDOYDULDELOLW\LQWKHDPSOLWXGHDnd 
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ODWHQF\RI&31WLPHFRXUVHYDULDELOLW\VSHFWUDOSRZHUYDULDELOLW\LHDFURVVဨWULDO
variability in absolute alpha power, relative alpha power, absolute beta power, and relative 
EHWDSRZHUDQGPHDQVLJQDOဨWRဨQRLVHUDWLR615)XUWKHUWRWKHse measures, we analyzed 
mean visual evoked potentials and spectral power (both absolute and relative alpha and beta 
frequencies) to facilitate comparisons with other studies relating to associated disorders and 
similar CNVs (e.g. ASD, 15q, 1q). 
Materials and Methods 
 
Participants  
The findings in this article represent the analyses of a previously collected dataset (Simons 
Variation in Individuals Project [SVIP]) [The Simons VIP Consortium, 2012], which was 
obtained via the Simons Foundation Autism Research Initiative (SFARI) data request process 
(https://sfari.org/resources/sfari-base/request-data-and-biospecimens). The data of 
LQGLYLGXDOVZLWKS&19Va(?NES%3ဨ%3'(/RU'83DQGW\SLFDOO\
developing individuals were obtained from the SFARI database [The Simons VIP 
Consortium, 2012]. Participant identification, recruitment, and inclusion/exclusion criteria of 
the SVIP have been described previously [see The Simons VIP Consortium, 2012; Jenkins et 
al., 2016; LeBlanc & Nelson, 2016]. 
The control participants analyzed in this study did not undergo the Simon's VIP battery of 
assessments. LeBlanc and Nelson [2016] recruited the control group independently through 
the Boston Children's Hospital participant registry. The group consisted of neurotypical 
individuals without any neurological or developmental disorders. 
Data from a total of 46 participants were obtained from the SVIP consortium for the current 
study. Seven participants were then excluded. Reasons for exclusions were: visual inspection 
indicated that EEG data were contaminated by artifacts (n = 2) and/or EEG datasets contained 
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fewer than 24 clean trials. The final dataset analyzed contained 39 participants: 8 DUP, 20 
DEL, and 11 typically developing individuals. 
Phenotypic data including intelligence quotient (IQ) scores, diagnoses, current medications, 
and vision problems were accessed from the Simons VIP Phase 1 16p11.2 dataset at SFARI 
Base (http://www.sfari.org/resources/sfari-base ). Participant information relating to age, 
gender, CNV inheritance, $6'GLDJQRVLV$XWLVP'LDJQRVWLF2EVHUYDWLRQ6FKHGXOHဨ
&DOLEUDWHG6HYHULW\6FRUH$'26ဨ&66DQG,4VFRUHVDUHUHSRUWHGLQ7DEOH 1. Note that the 
reported IQ scores were not adjusted for prematurity. Other diagnoses and comorbidities are 
reported in Supporting Information Table S1. Information regarding current medication was 
extracted from the SFARI medication questionnaire (med_child.csv); two DEL carriers were 
reported to have been currently taking antiepileptic medication (i.e., Keppra and Topamax). 
Additionally, vision problems were reported for eight DEL and four DUP carriers in the 
SFARI development and medical history form (mhi_ped.csv). 
Kruskal±Wallis tests revealed that there were no significant age or sex differences among the 
three groups (Ȥ2 (2) = 1.46, P = 0.481; Ȥ2 (2) = 0.65, P = 0.724). Also, there were no 
VLJQLILFDQWGLIIHUHQFHVLQ,4VFRUHVIXOOဨVFDOH,4 Ȥ2 (1) = 2.97, P = 0.085; verbal IQ: Ȥ2 (1) = 
2.34, P = 0.126; nonverbal IQ: Ȥ2 (1) = 1.71, P = 0.191) between DEL and DUP groups. 
Comparisons with the control group were not possible as, other than age and gender, 
participant details and phenotypic data were not available for the typical control group. 
Ethical approval 
The local institutional ethical review board reviewed and approved the secondary analyses 
presented here. Our request to obtain access to phenotypic and imaging data on SFARI Base 
was approved after submitting the required information and signing the joinder to the 
researcher distribution agreement (https://www.sfari.org/resource/sfari-base/). SFARI 
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obtained initial ethical approval for the SVIP (IRB of record: Columbia University Medical 
Center) [The Simons VIP Consortium, 2012]. As part of the SVIP, approval was obtained for 
data collection on individuals with 16p11.2 deletions or duplications and for their 
deidentified data to be shared with approved researchers. 
Stimuli and procedure 
The stimuli and procedure were as described in previous studies [LeBlanc & Nelson, 2016; 
LeBlanc et al., 2015; Varcin et al., 2016]. 
 
EEG pre-processing conducted in the current study 
EEG recording and preprocessing steps conducted prior to the current study are described in 
Supporting Information. Additional preprocessing steps were conducted by the current 
authors after obtaining the dataset, which consisted of rejecting obvious bad trials (three trials 
in total) based on manual visual inspection. In addition, the number of trials selected for 
analysis was adjusted per group in order to control the average number of trials analyzed per 
group and avoid bias in analysis outcomes [original trial number range after participant 
exclusions: 24±147; original mean trial number for control = 67, original mean for DEL = 49, 
original mean for DUP = 71; new trial number range: 24±97; new mean = 49 trials per 
group]. This was done via an algorithm that applied a different number of trial limits per 
participant depending on the group the respective participant belonged to, which in turn was 
designed to result in the same trial number averages for all groups. 
 
EEG channel selection 
In accordance with previous studies [e.g., Foxe & Simpson, 2002; Milne, 2011*RQHQဨ
Yaacovi et al., 2016; Arazi, Censor, & Dinstein, 2017], for each participant, the channel 
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within the occipital and parietal regions with the highest amplitude within the time window 
60±(?PVSRVWVWLPXOXVRQVHWwas selected for timecourse variability analyses and C1, P1, 
and N1 analyses (both mean and variability analyses; Supporting Information Table S2). We 
also analyzed data based on an alternative criterion of selecting the channel with the lowest 
C1 amplitude, highest P1 amplitude, and lowest N1 amplitude for the respective C1, P1, and 
N1 analyses (both mean and variability analyses; Supporting Information Table S3); this 
analysis produced identical variability results, in addition to certain minor differences in the 
mean ERP results (see the Results section). For power analyses and SNR analyses, the 
average of a set of channels positioned above the occipital cortex was computed (Supporting 
Information Fig. S1). 
 
Extracting C1, P1, and N1 amplitude and latency  
&3DQG1ZHUHLGHQWLILHGIRUHDFKWULDODQGSDUWLFLSDQW8VLQJDSHDNဨSLFNLQJDOJRULWKP
which identified either the maximum or minimum amplitude within a given time window, 
negative and positive deflection points were identified in overlapping period ranges 
consistent with those previously reported by LeBlanc and Nelson [2016]. C1 was identified 
as the minimum amplitude occurring in the poststimulus period range of 0±(?PV3ZDVWKH
highest amplitude in the period range of 56±(?PV1ZDVWKHORZHVWDPSOLWXGHLQWKH±
(?PVUDQJH7KHDPSOLWXGHDQGODWHQF\RI&3DQG1ZHUHILUVWH[WUDFWHGIURPHYHU\
trial. RespHFWLYHO\WKH&3DQG1DYHUDJHVLQJOHဨWULDODPSOLWXGHVZHUHWKHQJLYHQE\
FRPSXWLQJWKHPHGLDQRIDOOWKHVLQJOHဨWULDO&3DQG1DPSOLWXGHGHIOHFWLRQSRLQWV
6LPLODUO\&3DQG1DYHUDJHVLQJOHဨWULDOODWHQF\ZHUHJLYHQE\WKHPHGLDQRIDOOthe 
VLQJOHဨWULDOWLPHSRLQWVDWZKLFKWKH&3DQG1DPSOLWXGHSHDNVWKHUHIRUHIROORZLQJWKH
same approach as Milne [2011]). 
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Measures of neural variability  
Because there are many variables that have been suggested to indicate neural variability [e.g., 
Milne, 2011; Weinger, Zemon, Soorya, & Gordon, 2014; Haigh et al., 2016; Arazi et 
al., 2017; Butler, Molholm, Andrade, & Foxe, 2017], it is good practice to apply more than 
one measure and examine whether there is concordance between the metrics. Measures of 
neural variability examined in the current study were C1, P1, and N1 variability; intertrial 
variability in ERP amplitude across the timecourse (timecourse variability); alpha and beta 
power variability; and EEG SNR. Although it could be argued that SNR is not a true 
reflection of intertrial variability, it is often used as a proxy measure of variability, with lower 
SNRs interpreted as higher neural variability [Dinstein et al., 2012; Butler et al., 2017]. Thus, 
SNR is provided in the current study for comparison with previous research. 
 
C1, P1, N1, and timecourse variability  
For each participant, C1, P1, and N1 variability were given by computing the median 
absolute deviation (MAD) of the single trial amplitude and latency values. Timecourse 
variability was given by computing the MAD of all 2 ms interval amplitudes across trials for 
the full length of the signal in order to investigate the precise timing of any differences in 
variability between the three groups. In other words, we computeGWKH0$'RIVLQJOHဨWULDO
amplitudes of each individual datapoint in the signal (encompassing all the prestimulus and 
SRVWVWLPXOXVSHULRGVUDQJHí(?PV(?PV 
 
Alpha and beta power variability 
Power variability was given by computing the MAD of singlHဨWULDODEVROXWHDQGUHODWLYH
alpha (8±(?+]DQGEHWDSRZHU±(?+]IRUHDFKSDUWLFLSDQWVHH6XSSRUWLQJ,QIRUPDWLRQ
for detailed methodology). Mean absolute and relative alpha and beta power were also 
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measured to facilitate comparisons with other studies. These analyses were conducted using 
LQဨKRXVHFRGHFRGHDYDLODEOHXSRQUHTXHVWGHULYHGIURPFRGHVVKDUHGE\'U0LNH;
Cohen [Cohen, 2014] with functions from the EEGlab toolbox [Delorme & Makeig, 2004].  
 
Signal-to-noise ratio 
615LVWKHUDWLRRISRVWVWLPXOXVVLJQDOLHWR(?PVLQWKHFXUUHQWVWXG\strength to the 
SUHVWLPXOXVVLJQDOLHíWRPVUHODWLYHWRVWLPXOXVWLPHVWUHQJWKWKHODWWHU
traditionally termed as noise) and is usually expressed in decibels. The current study followed 
the same SNR formula used in Butler et al. [2017] to compute SNRs (see Supporting 
Information for detailed methodology). 
 
Statistical Analysis 
As sample sizes were small and the data were skewed, permutation tests were conducted to 
investigate whether there were group differences in neural activity between the three groups 
[see Rodgers, 1999]. The advantage of this technique is it makes no a priori assumptions 
about the distribution of the data and uses the actual data to conduct the test. For each group 
comparison (i.e., DEL/control, DUP/control, and DEL/DUP), the whole group data were 
randomly permuted, this new permuted data were assigned to two groups with identical 
sample sizes to the respective original dataset. The mean difference between these two new 
groups was calculated; this procedure was then repeated 10,000 times. The actual absolute 
mean difference was compared to the randomized distribution of absolute mean differences. 
The P value is the number of (absolute) mean differences' values above the actual (absolute) 
mean difference obtained and divided by the number of iterations (10,000). This was 
conducted for each EEG averaged and variability metric described in earlier sections. To 
account for multiple companions, the false discovery rate (FDR) was controlled using the 
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Benjamini±Hochberg procedure, with q(?(?:HDOVRDSSOLHGWKHSHUPXWDWLRQDSSURDFKWR
correlation analyses to examine whether age, IQ, and autistic traits impact neural responses in 
16p11.2 CNV carriers. For each group, the null hypothesis (P = 0) is tested by holding the Xဨ
YDULDEOHHJDJHFRQVWDQWDQGSHUPXWLQJWKH<ဨYDULDEOHHJ3DPSOLWXGHYDULDELOLW\
against it. In other words, the rဨFRHIILFLHQWIRUWKHUHVSHFWLYHDFWXDO;ဨYDULDEOHDQGWKH
UDQGRPSHUPXWDWHG<ဨYDULDEOHSDLULVFRPSXWHGZLWKWKHH[SHFWDWLRQRI r = 0. This process is 
repeated 10,000 times, where only the YဨYDULDEOHLVSHUPXWHG7KHDFWXDODEVROXWH rဨ
coefficient of the respective variables were then compared to the randomized distribution of 
absolute rဨFRHIILFLHQWVZKLFKZHUHSURGXFHGE\WKHFRUUHODWLRQSHUPXWDWLRQV7KH Pဨ
value is the number of (absolute) rဨFRHIILFLHQWV
YDOXHVDERYHWKHDFWXDODEVROXWH rဨ
coefficients obtained and divided by the number of iterations (10,000). All the outcomes were 
corrected for FDR using the Benjamini±Hochberg procedure, with q(?(? 
Results 
C1, P1, N1, and timecourse variability 
DEL, DUP, and control group averages and differences in the variability of C1, P1, and N1 
amplitude and latency are presented in Tables 2 and 3. Significant differences were found in 
P1 amplitude variability (Fig. 1A) between DEL and controls. Specifically, DEL showed 
significantly higher variability in P1 amplitude compared to controls. Also, DEL showed 
significantly lower variability in P1 latency compared to DUP (Fig. 1B). No other significant 
differences were found between the three groups in C1, P1, and N1 intraparticipant 
variability. 
 
7LPHFRXUVHYDULDELOLW\WKDWLVWULDOဨWRဨWULDOYDULDELOLW\LQWKHDPSOLWXGHRIHDFKLQGLYLGXDO
GDWDSRLQWPVLQWKHVLJQDO>UDQJHí(?PV(?PV@ZDVDO RFRPSDUHGEHWZHHQWKHWKUHH
JURXSVFRPSDUHGWRFRQWUROV'(/VKRZHGKLJKHUPVဨLQWHUYDOWULDOဨWRဨWULDOYDULDELOLW\
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DOPRVWFRQVHFXWLYHO\IRUWKHZKROHSHULRGEHWZHHQíDQG(?PVOHQJWKRIJDSV(?PV
DQGDW(?PVVHH)LJ 2 for a precise illustration of the timepoints during the epoch where 
timecourse variability was significantly greater in DEL than controls). No other differences 
were found in timecourse variability between the three groups. 
 
Mean amplitude and latency of C1, P1, and N1 were compared between the three groups 
(Tables 2 and 3). DEL showed higher C1 (i.e., lower negative peak) amplitude compared to 
controls. Note that when the channel selected for analysis was based on the alternative 
criterion of selecting the electrode showing the lowest C1 and N1 amplitude for the 
respective C1 and N1 analyses, this group difference was no longer significant and a new 
result of increased C1 latency in DUP compared to controls was found. In line with LeBlanc 
and Nelson [2016], DEL showed higher P1 amplitude compared to DUP. No other significant 
differences were found. 
 
Alpha and beta power variability 
7ULDOဨWRဨWULDOYDULDELOLW\LQDEVROXWHDQGUHODWLYHSRZHUZLWKLQWKHDOSKDDQGEHWDIUHTXHQF\
bands were compared between the three groups (Tables 2 and 3). Variability in absolute 
alpha and beta power was significantly higher for DEL compared to DUP (Fig. 3A and B). 
No other significant group differences were found in alpha or beta power variability. 
 
Mean absolute and relative power in the alpha and beta frequency bands were also compared 
between the three groups (Tables 2 and 3). Relative alpha power was lower for DUP 
compared to controls. Additionally, absolute alpha and absolute beta power were higher for 
DEL compared to DUP. No significant group differences were found in mean alpha or beta 
power. 
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Signal-to-noise ratio 
The analysis revealed no significant differences in SNR between the three comparisons 
(Tables 2 and 3). 
 
Correlations between IQ, ADOS-CSS, and EEG measures in 16p CNV 
For each of the DEL and DUP groups, correlation permutation tests [Rodgers, 1999] were 
SHUIRUPHGEHWZHHQ,4DQG$'26ဨ&66DJDLQVW((*PHDVXUHVRILQWHUHVW&3DQG1
variability; alpha and beta power variability; SNR; C1, P1, and N1 mean; alpha and beta 
power mean), respectively. No significant correlations were found (Supporting Information 
Table S4). 
 
The impact of age on neural activity 
For each of the three groups, correlation permutation tests were performed between age and 
the EEG measures of interest (C1, P1, and N1 variability; alpha and beta power variability; 
SNR; C1, P1, and N1 mean; alpha and beta power mean), respectively. No significant 
correlations were found (Supporting Information Table S5). 
The number of trials available for analysis differed for each subject which could potentially 
influence estimates of variability. Thus, to investigate whether the number of trials per 
subject was associated with variability, SNR, and/or averaged EEG measures, permutation 
correlation tests [Rodgers, 1999] were conducted, and the outcomes were corrected using the 
Benjamini±Hochberg procedure, with q(?(?7KHUHVXOWVVKRZHGWKDWWKHUHZHUHQR
significant relationships between the EEG measures and trial number (Supporting 
Information Table S6). In the current study, the number of retained trials in the three groups 
were the same on average (mean = 49 trials per group, Kruskal±Wallis [Ȥ2 (2) = 0.58, P = 
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0.748] indicates no difference in median). Therefore, the variable trial number per participant 
is unlikely to explain any observed group differences in any of the EEG measures of interest. 
Discussion 
 
The aim of the study was to determine whether 16p11.2 CNVs show opposing atypical EEG 
signals, which could broadly indicate genHဨGRVDJHHIIHFWVSOD\LQJDGLIIHUHQWLDOUROHLQ
cognitive processes and neural plasticity. Multiple measures of neural variability were 
HVWLPDWHGIURP((*GDWDPRVWRIZKLFKZHUHVLQJOHဨWULDOLQWUDSDUWLFLSDQWDQDO\VHV2YHUDOO
our results suggest that 16p11.2 DEL carriers showed highly variable neural responses to 
visual stimuli, compared to controls. Variability of timecourse amplitude (i.e., variability in 
DPSOLWXGHDWWLPHဨSRLQWVWKURXJKRXWWKHHSRFK)LJ 2) and variability of P1 peak amplitude 
were higher in DEL compared to controls. Compared to DUP, DEL showed higher variability 
in absolute alpha and beta power but lower variability in P1 latency variability. Overall, it is 
unclear from our findings whether 16p11.2 dosage has an opposing effect on neural activity. 
Despite finding significant differences in neural variability between DEL and DUP, we did 
not find any differences between DUP and controls (althRXJKQRWHWKDWZHGLGILQG'83ဨ
control group differences in mean relative alpha power). Differences in neural activity 
between DEL and DUP are not sufficient evidence of an opposing effect. For a true opposing 
effect to be seen, we would need to show that both groups differ in opposing directions from 
the control group. 
 
Is atypical neural variability unique to 16p11.2 CNVs? 
Atypical neural variability has been shown in several diagnoses including ASD [Milne, 2011; 
Dinstein et al., 2012; Weinger et al., 2014; Edgar et al., 2015; Haigh et al., 2015, 2016; but 
see Coskun et al., 2009; and Butler et al., 2017], attention deficit hyperactivity disorder 
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(ADHD) [Woltering, Jung, Liu, & Tannock, 2012; McLoughlin, Palmer, Rijsdijk, & 
Makeig, 2014*RQHQဨ<DDFRYLHWDO 2016; Sørensen, Eichele, van Wageningen, Plessen, & 
Stevens, 2016], and schizophrenia [Shin et al., 2015; Haigh et al., 2016]. Interestingly, all of 
these conditions are associated with 16p11.2 CNVs [Williams et al., 2010; Sanders et 
al., 2011; Snyder et al., 2016; Marshall et al., 2017]. For example, similar to the current 
study's finding with respect to P1 variability found in DEL, atypically high visual evoked P1 
amplitude variability was also reported for ASD [Milne, 2011@DQG$'+'JURXSV>*RQHQဨ
Yaacovi et al., 2016]. However, Milne [2011] also found atypical P1 latency variability in 
ASD, whereas here, neither the DEL or DUP group showed latency variability that differed 
from the control group, although, P1 latency variability was decreased in DEL compared to 
DUP. Further group differences between DEL and DUP in neural variability were found in 
EEG spectral power; here, DEL showed higher absolute power variability, in beta and alpha 
bands, compared to DUP (again, neither CNV groups differed in power variability when 
compared to controls). Woltering et al. [2012] similarly reported lower (absolute) alpha and 
beta power variability in ADHD compared to controls [Woltering et al., 2012]. 
Previous studies also found higher timecourse variability in ADHD (time window: 0±(?PV
>*RQHQဨ<DDFRYLHWDO 2016] and time window: 0±(?PV>0\DWFKLQ/HPLHUH'DQFNDHUWV
& Lagae, 2012@VLPLODUWRRXUILQGLQJLQUHODWLRQWRWLPHFRXUVHYDULDELOLW\LQ'(/*RQHQဨ
Yaacovi et al. [2016] also computed baseline variability (previsual stimulus onset; time 
ZLQGRZíဨPVDQGUHSRUWHGKLJKHUYDULDELOLW\LQ$'+'²again consistent with our 
DEL findings. There is an extensive literature on the putative interactions between evoked 
and ongoing activity raising the possibility that the increased variability prior to stimulus 
onset contributed to that observed poststimulus [Busch, Dubois, & VanRullen, 2009]. 
Standard approaches to correct baseline simply subtract the average of the prestimulus period 
from each trial and do not take into account variability both in the prestimulus timeseries of 
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single trials or variability across trials. As such, it is important to examine both ERP 
amplitude and variability before and after stimulus onset. 
Evidently, it would not be plausible to regard atypical neural variability, whether in the form 
of P1 variability, timecourse variability, or other, as distinct to 16p11.2 CNVs in light of the 
several heterogeneous disorders that show general similar variability dynamics. Rather, this 
study highlights that 16p11.2 CNVs²specifically deletions²should be added to the list of 
clinical conditions which show increased neural variability. The overall picture alludes to 
certain similarities in the behavior of neural responses, which would be informative and 
useful for further investigations. 
 
Interpreting neural variability 
Although, neural variability has become a topic of interest in many research areas including 
clinical populations [Pernet et al., 2011; Garrett et al., 2013; Dinstein et al., 2015; Butler et 
al., 2017; David et al., 2016], the interpretation of neural variability remains a challenge. 
Nevertheless, it has been widely recognized that optimal neural variability is a characteristic 
of typical and healthy brain function, facilitating learning, adaptation to a changing 
environment, and other cognitive processes [Basalyga & Salinas, 2006; Faisal, Selen, & 
Wolpert, 2008; McDonnell & Abbott, 2009; Heisz, Shedden, & McIntosh, 2012]. Deviations 
from the typical levels of neural variability in the 16p11.2 DEL group, therefore, could be 
regarded as a signature of neuropathology and cognitive dysfunction, as was similarly 
indicated in the aforementioned studies of related disorders. IQ and autism symptom severity 
did not relate to any of the neural variability and averaged measures in the current study's 
16p11.2 CNV sample (Supporting Information Table S4). Although consistent with previous 
studies [LeBlanc & Nelson, 2016; Jenkins et al., 2016] this lack of relationship could simply 
be due to sample size and needs to be further validated in future studies with larger samples. 
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Furthermore, neural variability could be related to other 16p11.2 CNV symptoms and traits, 
which could not be revealed via the phenotypic assessments used in the current and previous 
studies. 
Of note, a recent study suggested that neural variability (on a macrolevel as measured by 
intertrial variation of the BOLD signal) is negatively related to dopamine concentration 
OHYHOVTXDQWLILHGXVLQJ3(7>*XLWDUWဨ0DVLSHWDO 2016]. In a mouse model of 16p11.2 CNV 
[Portmann et al., 2014@GRSDPLQHဨUHODWHGGHILFLWVZHUHIRXQGLQWKHEDVDOJDQJOLDWKHUHIRUH
indicating the potential role of certain genes within the 16p11.2 region in establishing typical 
dopaminergic synaptic activity. Accordingly, a potential factor driving atypical neural 
variability in the CNV groups could be the dysregulation of dopamine levels; this, in turn, 
would lead to deficits in processes mediated by dopamine such as motivation and learning 
processes, movement, and social behavior [Wise, 2004; Portmann et al., 2014], all of which 
are seen in 16p11.2 CNV carriers and related disorders. 
The observed atypical EEG activity in 16p11.2 CNV carriers could also reflect cellular 
electrophysiological and synaptic abnormalities. To examine cellular characteristics of 
16p11.2 CNV carriers, a recent study used fibroblasts obtained from 16p11.2 CNV carriers 
and generated induced pluripotent stem cells, which were then differentiated into (forebrain 
cortical) neurons [Deshpande et al., 2017]. Compared to neurons derived from typical 
controls, the authors found an increase in the amplitude of miniature excitatory postsynaptic 
currents in both DEL and DUP (excitatory) neurons. As the authors suggest, the increase in 
amplitude may be compensating for the reduced density of synapses in the CNV neurons. 
These altered cellular properties could affect overall neural plasticity and connectivity, which 
ultimately leads to the behavioral symptoms related to 16p11.2 CNV carriers and possibly to 
the activity recorded by EEG. Indeed, our EEG findings of atypical neural variability in 
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16p11.2 CNV carriers could signify synaptic impairment of excitatory neurons as that 
observed in vitro [Deshpande et al., 2017] and also possibly of dopaminergic neurons. 
Limitations 
Although we addressed the issue of small sample size with randomization techniques, larger 
datasets would have been desirable to enable examination of confounding variables such as 
epilepsy than was possible here. A further limitation is the lack of IQ data for the control 
group. As participant IQ data were not available for the typical control participants, it was not 
possible to adequately account for cognitive ability in this study. Although in our current 
sample there were no IQ differences between DEL and DUP, other larger scale phenotypic 
studies have reported differing IQ profiles, with the DUP group tending to show higher IQ 
[Hippolyte et al., 2016] and a wider range of IQ scores [D'angelo et al., 2016]. A further 
limitation concerns the wide age ranges of the participants in the three groups. Consistent 
with LeBlanc and Nelson [2016], we found no effect of age on any of the EEG measures of 
interest (Supporting Information Table S5). Furthermore, our sample showed no significant 
group differences in age. This, however, does not preclude the possibility of some minor 
effect of maturational changes on neural variability, which might be better expressed in a 
different 16p11.2 CNV sample. 
 
Concluding remarks. 
The overall results, drawn from multiple measures of neural variability, strongly suggest that 
S'(/FDUULHUVLQSDUWLFXODUVKRZYLVXDOဨHYRNHGQHXUDOUHVSRQVHVWKDWDUHKLJKO\
variable compared to controls. Levels of neural variability were atypical and, thus, were 
postulated to have deviated from the optimal variability levels necessary for healthy brain 
function and cognitive processing. Future work should corroborate current findings using a 
ODUJHUVDPSOHDQGFRQGXFWIXUWKHUJURXSFURVVဨFRPSDULVRQVDPRQJS&19JURXSV
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CNV inheritance (de novo vs. inherited CNV), associated disorders (e.g., ASD), and similarly 
rare deleterious CNVs. 
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Tables 
 
Table 1. Participant information 
 
Group N Age 
mean in 
months 
(SD) 
Age 
range in 
months 
Gender CNV inheritance ASD diagnosisc ADOS-
CSS 
mean 
(SD)a c d 
FSIQ 
mean 
(SD)b c d 
VIQ 
mean 
(SD)b c d 
NVIQ 
mean 
(SD)b c d 
De 
novo 
Inherited unknown Yes No unknown     
DEL 20 69.05 
(36.93) 
12 - 163 M 12 7 2 3 2 8 2 4.29 
(2.87) 
78.32 
(14.23) 
72.84 
(16.22) 
83.58 
(14.93) 
 
   F 8 6 1 1 2 6 0     
DUP 8 110 
(86.22) 
40 - 256 M 4 0 4 0 1 3 0 2.71 
(1.50) 
82.25 
(13.29) 
83.63 
(17.61) 
84.88 
(10.23) 
 
   F 4 1 3 0 0 4 0     
Typical 11 68.36 
(23.31) 
39 - 109 M 5 - - - - - - - - - - 
 
   F 6 - - - - - - - - - - 
ADOS-CSS Autism Diagnostic Observation Schedule - Calibrated Severity Score; FSIQ full-scale IQ, VIQ verbal IQ, NVIQ nonverbal IQ.  
a0LVVLQJGDWDIURP'(/FDUULHUVQ(? (?'83FDUULHUVQ W\SLFDOJURXSQ(? (? 
b0LVVLQJGDWDIURP'(/FDUULHUVQ(? (?W\SLFDOJURXSQ(? (? 
cIQ and diagnosis data were extracted from diagnosis_summary.csv 
dThe reported IQ scores were not adjusted for prematurity.
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Table 2.   Variability and averaged measures of neural activity of 16p CNV. 
 
 DEL Control DUP 
C1, P1, N1 variability C1 amplitude (µV) 15.2 [6  17.75] 12.18 [3.91  14.39] 12.11 [4.5  17.8] 
 
C1 latency (ms) 21.5 [10  31] 16 [2  26] 16 [6  24] 
 
P1 amplitude (µV) 17.67 [10.17  26.27] 11.01 [5.48  19.4] 13.62 [3.11  25.25] 
 
P1 latency (ms) 8 [4  16] 10 [4  24] 13 [8  26] 
 
N1 amplitude (µV) 19.4 [9.52  25.88] 14.54 [6  26] 17.56 [4.02  30.51] 
 
N1 latency (ms) 34.5 [12  56] 32 [23  40] 42 [22  52] 
 
    
Power variability Absolute alpha (µV2) 13.39 [7.36  44.27] 9.01 [2.78  34.85] 8.10 [1.49  14.28] 
 
Relative alpha (%) 0.09 [0.05  0.17] 0.11 [0.07  0.14] 0.08 [0.04  0.09] 
 
Absolute beta (µV2) 5.36 [1.93  19.74] 3.15 [0.54  10.55] 2.28 [1.25  5.35] 
 
Relative beta (%) 0.04 [0.02  0.09] 0.05 [0.03  0.06] 0.04 [0.01 0.07] 
 
    
SNR (dB) 4.73 [3.22  6.29] 4.89 [3.93  7.87] 4.83 [4.40  6.35] 
 
    
C1, P1, N1 mean C1 amplitude (µV) 0.03 [-10.23  6.48] -6.49 [-20.1  0.52] -4.54 [-7.91  -1.41] 
 
C1 latency (ms) 40 [2  72] 64 [20  70] 52 [2  72] 
 
P1 amplitude (µV) 23.13 [8.08  43.06] 14.42 [1.47  28.73] 10.41 [3.21  16.76] 
 
P1 latency (ms) 98 [78  126] 98 [68  134] 92 [88  134] 
 
N1 amplitude (µV) -10.05 [-24.53  5.83] -7.8 [-13.08  -1.34] -7.3 [-11.79  -0.53] 
 
N1 latency (ms)  213 [144  268] 210 [136  250] 199 [162  268] 
 
    
Power mean Absolute alpha (µV2) 31.62 [18.01  98.28] 24.52 [5.95  51.55] 18.18 [3.60  35.93] 
 
Relative alpha (%) 0.20 [0.14  0.35] 0.23 [0.18  0.33] 0.16 [0.12  0.23] 
 
Absolute beta (µV2) 15.48 [6.09  66.96] 10.08 [1.81  22.92] 6.78 [3.40  13.38] 
 
Relative beta (%) 0.10 [0.04  0.24] 0.11 [0.08  0.16] 0.09 [0.05  0.20] 
The data are reported as median [range]. 
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Table 3.  Group differences in variability and averaged measures of neural activity of 16p CNV.  
  DEL/Control DUP/Control DEL/DUP 
  
Actual 
difference 
P-value Actual 
difference 
P-value Actual 
difference 
P-value 
C1, P1, N1 
variability 
C1 amplitude (µV) 2.92 0.048 1.45 0.437 1.48 0.330 
 
C1 latency (ms) 7.25 0.010 1.45 0.702 5.80 0.020 
 
P1 amplitude (µV) 6.16 0.001 2.79 0.282 3.37 0.100 
 
P1 latency (ms) 0.80 0.650 5.05 0.108 5.85 0.003 
 
N1 amplitude (µV) 4.01 0.080 3.15 0.368 0.86 0.724 
 
N1 latency (ms) 5.61 0.154 9.66 0.021 4.05 0.372 
 
       
Power 
variability 
Absolute alpha (µV2) 4.67 0.226 4.80 0.231 9.47 0.004 
 
Relative alpha (%) 0.01 0.510 0.03 0.016 0.02 0.064 
 
Absolute beta (µV2) 2.28 0.085 1.17 0.325 3.45 0.002 
 
Relative beta (%) < 0.01 0.599 <0.01 0.950 <0.01 0.687 
 
       
SNR (dB) 0.23 0.556 0.04 0.931 0.27 0.400 
 
       
C1, P1, N1 
mean 
C1 amplitude (µV) 6.50 0.006 2.75 0.349 3.75 0.025 
 
C1 latency (ms) 18.07 0.022 9.52 0.277 8.55 0.323 
 
P1 amplitude (µV) 8.65 0.010 3.06 0.359 11.71 0.0003 
 
P1 latency (ms) 0.45 0.926 1.45 0.862 1.00 0.836 
 
N1 amplitude (µV) 0.98 0.702 0.63 0.728 1.61 0.565 
 
N1 latency (ms)  20.41 0.191 20.91 0.284 0.50 0.975 
 
       
Power 
mean 
Absolute alpha (µV2) 13.87 0.067 8.22 0.225 22.09 0.003 
 
Relative alpha (%) 0.02 0.208 0.07 0.003 0.04 0.019 
 
Absolute beta (µV2) 7.51 0.053 2.78 0.289 10.29 0.003 
 
Relative beta (%) 0.01 0.731 <0.01 0.892 0.01 0.681 
     Significant results of permutation tests after correcting for FDR (significance threshold at p < 0.006) are in bold.  
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Figures 
 
 
 
 
 
 
 
 
 
Figure. 1 
P1 variability in 16p11.2 CNV. All three groups are presented similarly in both subfigures 
with the DEL group shown in blue, the DUP group shown in green, and the typical control 
groups shown in black. In addition, participants within the CNV groups with a diagnosis of 
autism spectrum disorder are indicated in purple. (A) The left graph shows scatter plots 
representing the distributions (median and range) of intraparticipant amplitude variability 
(MAD) of the peak P1 component, averaged across groups. (B) The right graph shows group 
distributions of latency variability of peak P1. 
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Figure. 2 
Timecourse variability in 16p11.2 CNV. Timecourse variability in 16p11.2 CNV. The DEL 
group is indicated with blue, DUP group with green, and control group with black. The figure 
VKRZVWKHWLPHFRXUVHYDULDELOLW\LHYDULDELOLW\LQDPSOLWXGHDWHDFKWLPHဨSRLQWPV
interval, throughout the signal) for all three groups. The gray shaded areas represent the 
durations by which DEL significantly differed from controls in amplitude (significance 
WKUHVKROGDW3(?(? 
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Figure. 3 
Alpha and beta power variability in 16p11.2 CNV. All three groups are presented similarly 
in both subfigures with the DEL group shown in blue, the DUP group shown in green, and 
the typical control groups shown in black. In addition, participants within the CNV groups 
with a diagnosis of autism spectrum disorder are indicated in purple. (A) The left subfigure 
shows scatter plots representing the group distributions of intraparticipant variability of 
absolute alpha power (8±(?+]%7KHULJKWVXEILJXUHVKRZVJURXSGLVWULEXWLRQVRI
absolute beta variability (14±(?+] 
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